372 related articles for article (PubMed ID: 18840879)
1. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.
Neil A; Cooper J; Betteridge J; Capps N; McDowell I; Durrington P; Seed M; Humphries SE
Eur Heart J; 2008 Nov; 29(21):2625-33. PubMed ID: 18840879
[TBL] [Abstract][Full Text] [Related]
2. Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
Humphries SE; Cooper JA; Seed M; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil HAW;
Atherosclerosis; 2018 Jul; 274():41-46. PubMed ID: 29751283
[TBL] [Abstract][Full Text] [Related]
3. Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
Neil HA; Hawkins MM; Durrington PN; Betteridge DJ; Capps NE; Humphries SE;
Atherosclerosis; 2005 Apr; 179(2):293-7. PubMed ID: 15777544
[TBL] [Abstract][Full Text] [Related]
4. Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register.
Humphries SE; Cooper JA; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil AHW;
Atherosclerosis; 2019 Feb; 281():207-212. PubMed ID: 30458964
[TBL] [Abstract][Full Text] [Related]
5. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
Atherosclerosis; 1999 Jan; 142(1):105-12. PubMed ID: 9920511
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
Neil HA; Huxley RR; Hawkins MM; Durrington PN; Betteridge DJ; Humphries SE;
Atherosclerosis; 2003 Sep; 170(1):73-8. PubMed ID: 12957684
[TBL] [Abstract][Full Text] [Related]
7. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.
BMJ; 1991 Oct; 303(6807):893-6. PubMed ID: 1933004
[TBL] [Abstract][Full Text] [Related]
8. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
9. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
Lancet; 2021 Nov; 398(10312):1713-1725. PubMed ID: 34506743
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
11. Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
Besseling J; Hovingh GK; Huijgen R; Kastelein JJP; Hutten BA
J Am Coll Cardiol; 2016 Jul; 68(3):252-260. PubMed ID: 27417002
[TBL] [Abstract][Full Text] [Related]
12. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
[TBL] [Abstract][Full Text] [Related]
13. Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.
Mundal L; Sarancic M; Ose L; Iversen PO; Borgan JK; Veierød MB; Leren TP; Retterstøl K
J Am Heart Assoc; 2014 Dec; 3(6):e001236. PubMed ID: 25468658
[TBL] [Abstract][Full Text] [Related]
14. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
Farnier M; Civeira F; Descamps O;
Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia.
Nherera L; Calvert NW; Demott K; Humphries SE; Neil HA; Minhas R; Thorogood M
Curr Med Res Opin; 2010 Mar; 26(3):529-36. PubMed ID: 20014994
[TBL] [Abstract][Full Text] [Related]
16. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
17. Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.
Anagnostis P; Vaitsi K; Mintziori G; Goulis DG; Mikhailidis DP
Curr Med Res Opin; 2020 May; 36(5):731-740. PubMed ID: 32096673
[No Abstract] [Full Text] [Related]
18. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
Fidan D; Unal B; Critchley J; Capewell S
QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
[TBL] [Abstract][Full Text] [Related]
19. Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study.
Huxley RR; Hawkins MH; Humphries SE; Karpe F; Neil HA;
Stroke; 2003 Jan; 34(1):22-5. PubMed ID: 12511745
[TBL] [Abstract][Full Text] [Related]
20. A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patients.
Versmissen J; Oosterveer DM; Yazdanpanah M; Mulder M; Dehghan A; Defesche JC; Kastelein JJ; Sijbrands EJ
Eur Heart J; 2011 Feb; 32(4):469-75. PubMed ID: 20595220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
